VTV THERAPEUTICS INC's ticker is VTVT and the CUSIP is 918385105. A total of 25 filers reported holding VTV THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,099 | -35.4% | 50,416 | 0.0% | 0.00% | – |
| Q2 2023 | $37,298 | +13.8% | 50,416 | +24.2% | 0.00% | – |
| Q1 2023 | $32,778 | +21.9% | 40,577 | 0.0% | 0.00% | – |
| Q4 2022 | $26,894 | -31.0% | 40,577 | 0.0% | 0.00% | – |
| Q3 2022 | $39,000 | +30.0% | 40,577 | 0.0% | 0.00% | – |
| Q2 2022 | $30,000 | +3.4% | 40,577 | 0.0% | 0.00% | – |
| Q1 2022 | $29,000 | -27.5% | 40,577 | 0.0% | 0.00% | – |
| Q4 2021 | $40,000 | -35.5% | 40,577 | 0.0% | 0.00% | – |
| Q3 2021 | $62,000 | -33.3% | 40,577 | 0.0% | 0.00% | – |
| Q2 2021 | $93,000 | -79.8% | 40,577 | -75.1% | 0.00% | – |
| Q1 2021 | $460,000 | +75.6% | 163,122 | +16.1% | 0.00% | – |
| Q4 2020 | $262,000 | +7.8% | 140,477 | +2.7% | 0.00% | – |
| Q3 2020 | $243,000 | -22.4% | 136,816 | -1.7% | 0.00% | – |
| Q2 2020 | $313,000 | +745.9% | 139,154 | +619.1% | 0.00% | – |
| Q1 2020 | $37,000 | +76.2% | 19,351 | +58.5% | 0.00% | – |
| Q4 2019 | $21,000 | +10.5% | 12,210 | 0.0% | 0.00% | – |
| Q3 2019 | $19,000 | +11.8% | 12,210 | 0.0% | 0.00% | – |
| Q2 2019 | $17,000 | -19.0% | 12,210 | 0.0% | 0.00% | – |
| Q1 2019 | $21,000 | -75.0% | 12,210 | -61.5% | 0.00% | – |
| Q4 2018 | $84,000 | +250.0% | 31,750 | +0.9% | 0.00% | – |
| Q3 2018 | $24,000 | -70.4% | 31,474 | -40.2% | 0.00% | – |
| Q2 2018 | $81,000 | -79.3% | 52,590 | -45.3% | 0.00% | – |
| Q1 2018 | $391,000 | -15.6% | 96,200 | +24.9% | 0.00% | – |
| Q4 2017 | $463,000 | +0.2% | 77,026 | -0.2% | 0.00% | – |
| Q3 2017 | $462,000 | +20.3% | 77,179 | -0.2% | 0.00% | – |
| Q2 2017 | $384,000 | -24.7% | 77,314 | -0.8% | 0.00% | – |
| Q1 2017 | $510,000 | +26.2% | 77,910 | -6.9% | 0.00% | – |
| Q4 2016 | $404,000 | -30.8% | 83,644 | +2.9% | 0.00% | – |
| Q3 2016 | $584,000 | +24.8% | 81,262 | +0.8% | 0.00% | – |
| Q2 2016 | $468,000 | +52.9% | 80,640 | +36.1% | 0.00% | – |
| Q1 2016 | $306,000 | -22.5% | 59,243 | +2.2% | 0.00% | – |
| Q4 2015 | $395,000 | +343.8% | 57,970 | +323.3% | 0.00% | – |
| Q3 2015 | $89,000 | – | 13,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 300,000 | $1,491,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 117,400 | $583,000 | 0.04% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 39,779 | $198,000 | 0.03% |
| Candriam S.C.A. | 140,000 | $696,000 | 0.01% |
| Alyeska Investment Group, L.P. | 204,523 | $1,016,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11,396 | $57,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $373,000 | 0.00% |
| FRANKLIN RESOURCES INC | 899,100 | $4,469,000 | 0.00% |
| AMERIPRISE FINANCIAL INC | 264,214 | $1,313,000 | 0.00% |
| SG Americas Securities, LLC | 12,845 | $64,000 | 0.00% |